Presynaptic dopamine D2 and muscarine M3 receptors inhibit excitatory and inhibitory transmission to rat subthalamic neurones in vitro

1 Whole‐cell patch‐clamp recordings were made from subthalamic nucleus (STN) neurones in brain slices from rats. Stimulation with bipolar electrodes evoked synaptic currents mediated by glutamate (EPSCs) and GABAA (IPSCs) receptors. 2 Dopamine reversibly reduced the amplitude of GABAA IPSCs by up to 48% with an IC50 value of 3.4 ± 0.8μm. The dopamine D2 receptor agonist quinpirole, but not the D1 receptor agonist SKF 82958, also inhibited GABAA IPSCs. This effect was completely reversed by the D2 receptor antagonist sulpiride but not by SCH 23390, a D1 antagonist. 3 Muscarine reversibly reduced the amplitude of GABAA IPSCs by up to 70 % with an IC50 value of 0.6 ± 0.1μm. Inhibition of IPSCs by muscarine was completely blocked by scopolamine (10 μm), a muscarinic receptor antagonist. The M3 muscarinic receptor antagonist 4‐DAMP effectively reversed muscarine‐induced inhibition of IPSCs with an IC50 of 0.11 ± 0.03μm. Although the M1 receptor antagonist pirenzepine also reversed the inhibition of IPSCs by muscarine, this effect was only observed at relatively high concentrations (IC50=21.7 ± 9.4μm). 4 Dopamine and muscarine both increased the paired‐pulse ratio of GABAA IPSCs. Neither agent produced sustained changes in postsynaptic holding current. 5 Glutamate EPSCs were also inhibited reversibly by dopamine (by up to 29 %; IC50= 16 ± 3 μm) and muscarine (by up to 41 %; IC50=1.0 ± 0.4μm). However, both agents were more potent and efficacious for reducing GABA IPSCs compared with glutamate EPSCs. 6 These results suggest that the most significant effect of dopamine and muscarine in the STN is to reduce inhibitory synaptic input by acting at presynaptic dopamine D2 and muscarinic M3 receptors, respectively.

[1]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[2]  Paul R. Adams,et al.  Voltage-clamp analysis of muscarinic excitation in hippocampal neurons , 1982, Brain Research.

[3]  L. Swanson.  The Rat Brain in Stereotaxic Coordinates, George Paxinos, Charles Watson (Eds.). Academic Press, San Diego, CA (1982), vii + 153, $35.00, ISBN: 0 125 47620 5 , 1984 .

[4]  F. F. Weight,et al.  Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis , 1985, Brain Research.

[5]  C. Hammond,et al.  Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus , 1986, Brain Research.

[6]  A. Crossman,et al.  Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders , 1987, Neuroscience.

[7]  T. Bonner,et al.  Identification of a family of muscarinic acetylcholine receptor genes. , 1987, Science.

[8]  H. Kita,et al.  Electrical membrane properties of rat subthalamic neurons in an in vitro slice preparation , 1987, Brain Research.

[9]  J. Palacios,et al.  Dopamine receptors in human brain: Autoradiographic distribution of D2 sites , 1989, Neuroscience.

[10]  J. Palacios,et al.  Dopamine receptors in human brain: Autoradiographic distribution of D1 sites , 1989, Neuroscience.

[11]  P. Robledo,et al.  Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data , 1990, Brain Research.

[12]  M. Delong,et al.  Primate models of movement disorders of basal ganglia origin , 1990, Trends in Neurosciences.

[13]  H. Bergman,et al.  Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. , 1990, Science.

[14]  S N Davies,et al.  Paired‐pulse depression of monosynaptic GABA‐mediated inhibitory postsynaptic responses in rat hippocampus. , 1990, The Journal of physiology.

[15]  A. Levey,et al.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Hollerman,et al.  Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol , 1992, Brain Research.

[17]  J. Zubieta,et al.  Autoradiographic mapping of M3 muscarinic receptors in the rat brain. , 1993, The Journal of pharmacology and experimental therapeutics.

[18]  I. Lucki,et al.  Dopaminergic Stimulation of Subthalamic Nucleus Elicits Oral Dyskinesia in Rats , 1994, Experimental Neurology.

[19]  S. Hernández,et al.  Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat , 1994, Brain Research.

[20]  A. Levey,et al.  Localization of muscarinic M3 receptor protein and M3 receptor binding in rat brain , 1994, Neuroscience.

[21]  Y. Hurd,et al.  The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons , 1994, Neuroscience.

[22]  J. Bolam,et al.  Cholinergic, GABAergic, and glutamate-enriched inputs from the mesopontine tegmentum to the subthalamic nucleus in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  S. Greenfield,et al.  Determinants of neuronal firing pattern in the guinea-pig subthalamic nucleus: Anin vivo andin vitro comparison , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[24]  R. Albin,et al.  The pathophysiology of chorea/ballism and Parkinsonism. , 1995, Parkinsonism & related disorders.

[25]  J. Penney,et al.  The functional anatomy of disorders of the basal ganglia , 1995, Trends in Neurosciences.

[26]  O. Hassani,et al.  Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus , 1996, Neuroscience.

[27]  J. Walters,et al.  Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons , 1996, Neuroscience.

[28]  J. Flores-Hernández,et al.  M3 muscarinic receptors mediate cholinergic excitation of the spontaneous activity of subthalamic neurons in the rat , 1996, Neuroscience Letters.

[29]  S. Johnson,et al.  Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones , 1997, The Journal of physiology.

[30]  O. Hassani,et al.  Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat , 1997, Brain Research.

[31]  J. Walters,et al.  The Response of Subthalamic Nucleus Neurons to Dopamine Receptor Stimulation in a Rodent Model of Parkinson’s Disease , 1997, The Journal of Neuroscience.

[32]  L. Potter,et al.  Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors. , 1998, The Journal of pharmacology and experimental therapeutics.

[33]  A. Benabid,et al.  Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 1998, The New England journal of medicine.

[34]  A L Benabid,et al.  Treatment of tremor in Parkinson's disease by subthalamic nucleus stimulation , 1998, Movement disorders : official journal of the Movement Disorder Society.

[35]  O. Hassani,et al.  Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study , 1999, Neuroscience.

[36]  C. Wilson,et al.  Mechanisms Underlying Spontaneous Oscillation and Rhythmic Firing in Rat Subthalamic Neurons , 1999, The Journal of Neuroscience.

[37]  E. Moro,et al.  Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease , 1999, Neurology.

[38]  R. Quirion,et al.  Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase–polymerase chain reaction and autoradiography , 1999, Neuroscience.